The IPO (initial public offer) of Hamps Bio, a small and medium-sized business (SME), got off to a great start on Friday, December 13. Within two hours of its launch, the issue was fully subscribed.
Out of the 11.58 lakh shares available, 39.44 lakh were applied for by investors in all categories.
Subscription across all categories
Retail investors' strong demand drove the Rs 6.22 crore Hamps Bio IPO to be oversubscribed 3.4 times. on the first day, according to BSE data.
In contrast to the 5.79 lakh shares allotted for the category, the portion designated for retail investors was 6.27 times subscribed for, with bidding a total of 36.34 lakh shares.
Just 53 per cent the shares in the Non-Institutional Investors (NIIs) category were subscribed for, with a total of 3.1 lakh shares, while 5.79 lakh shares were set aside for this segment.
Offer and structure
The fixed-price offering for the Hamps Bio IPO is valued at Rs 6.22 crore. The IPO is a brand-new 12.2 lakh share offering that does not include an offer-for-sale (OFS) component.
Price band and minimum bid
The IPO shares are being offered in lots of 2,000 at a fixed price of Rs 51 each.
Retail investors are eligible to apply for at least one lot size, with a Rs 1,02,000 minimum investment required for each application. High Net Worth Individuals (HNIs) must apply with a minimum of two lots of 4,000 shares, totalling Rs 2,04,000.
Subscription and listing dates
On December 18, the Hamps BioIPO share allocation status was confirmed to be finalized. By December 19, successful bidders can anticipate having their shares credited to their Demat Account, and refunds for unsuccessful bidders will be initiated that same day.
On December 20, shares of Hamps Bio are expected to go live on the BSE SME platform. Utilising the IPO process.
Use IPO proceedings
Hamps Bio has suggested using the money raised from the new issue to buy equipment and plants for its FMCG business. A portion of the money will also go toward general business objectives and raising brand awareness and visibility.
Company financials
Hamps Bio reported revenue of Rs 6.5 crore for the fiscal year 2023–24, up 16.4 per cent from Rs 5.6 crore for the fiscal year 2022–2023 before. In FY24, its net profit increased 39.5 per cent to Rs 50.07 lakh from FY23's Rs 35.9 lakh.
